Report Library
View More
Atopic Dermatitis (Eczema) KOL Inte...
February 23, 2026
Atopic Dermatitis (Eczema) KOL Inte...
February 23, 2026
Datamonitor Healthcare CV&Met Disea...
February 11, 2026
Datamonitor Healthcare Infectious D...
February 11, 2026
Datamonitor Healthcare CV&Met: Syst...
February 11, 2026
Datamonitor Healthcare Oncology: NH...
February 11, 2026
Datamonitor Healthcare Oncology: Ga...
February 11, 2026
Autism Spectrum Disorder (ASD) KOL ...
February 10, 2026
Autism Spectrum Disorder (ASD) KOL ...
February 9, 2026
Duchenne Muscular Dystrophy (DMD) K...
February 6, 2026
Duchenne Muscular Dystrophy (DMD) K...
February 6, 2026
Duchenne Muscular Dystrophy (DMD) K...
February 6, 2026
Dealmaking Quarterly Statistics, Q4...
February 5, 2026
Financing Quarterly Statistics, Q4 ...
February 5, 2026
Datamonitor Healthcare I&I: Axial S...
February 4, 2026
Datamonitor Healthcare CV&Met: Cach...
February 4, 2026
Datamonitor Healthcare Urology: Ove...
February 4, 2026
Datamonitor Healthcare Oncology: Bi...
February 4, 2026
Datamonitor Healthcare Oncology: Th...
February 4, 2026
Gene, Cell, & RNA Therapy Landscape...
February 3, 2026
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 2/18/26 | Novartis (NVS) | Rhapsido for Urticaria | Subscribers Only | Subscribers Only | Subscribers Only |
| 2/18/26 | Allievex | tralesinidase alfa for Mucopolysaccharidosis IIIB (MPS IIIB; Sanfilippo B Syndrome) | Subscribers Only | Subscribers Only | Subscribers Only |
| 2/17/26 | COMPASS Pathways (CMPS) | COMP360 for Major Depressive Disorder (MDD) | Subscribers Only | Subscribers Only | Subscribers Only |
| 2/15/26 | BridgeBio (BBIO) | Truseltiq for Achondroplasia | Subscribers Only | Subscribers Only | Subscribers Only |
| 2/13/26 | Novartis (NVS) | Vanrafia for Immunoglobulin A (IgA) Nephropathy (Berger's Disease) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 06/30/2022 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 10/22/2023 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |